These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 911594)

  • 1. Anaesthesia for patients susceptible to malignant hyperpyrexia. A study of pancuronium and methylprednisolone.
    Cain PA; Ellis FR
    Br J Anaesth; 1977 Sep; 49(9):941-4. PubMed ID: 911594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of procaine in the treatment of malignant hyperpyrexia.
    Clarke IM; Ellis FR
    Br J Anaesth; 1975 Jan; 47(1):17-21. PubMed ID: 1148070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procaine in malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1972 Dec; 4(5839):526-8. PubMed ID: 4642792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol anaesthesia in malignant hyperpyrexia susceptible swine.
    Foster PS; Hopkinson KC; Denborough MA
    Clin Exp Pharmacol Physiol; 1992 Mar; 19(3):183-6. PubMed ID: 1521353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for malignant hyperpyrexia.
    Nelson TE; Austin KL; Denborough MA
    Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of susceptibility to malignant hyperpyrexia in swine.
    Okumura F; Crocker BD; Denborough MA
    Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The control of muscle contracture by the action of dantrolene on the sarcolemma.
    Halsall PJ; Ellis FR
    Acta Anaesthesiol Scand; 1983 Jun; 27(3):229-32. PubMed ID: 6880584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.
    Ellis FR; Clarke IM; Modgill M; Currie S; Harriman DG
    Br Med J; 1975 Aug; 3(5982):511-3. PubMed ID: 1164612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N; Brum JM; Mitsumoto H; DeBoer GE
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyfort GH; Dupuis BA
    Br J Anaesth; 1990 Jan; 64(1):64-6. PubMed ID: 2302378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of halothane on adenylate kinase in porcine malignant hyperpyrexia.
    Marjanen LA; Denborough MA
    Clin Chim Acta; 1982 Jul; 122(2):225-30. PubMed ID: 6286170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of ephedrine, adrenaline, noradrenaline and isoprenaline on halothane-induced contractures in skeletal muscle from patients potentially susceptible to malignant hyperthermia.
    Urwyler A; Censier K; Seeberger MD; Rothenbühler JM; Kaufmann MA; Drewe J
    Br J Anaesth; 1993 Jan; 70(1):76-9. PubMed ID: 8431339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in onset of porcine malignant hyperthermia.
    Gronert GA; Milde JH
    Anesth Analg; 1981 Jul; 60(7):499-503. PubMed ID: 7195665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
    Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Reyford HG; Adamantidis MM; Dupuis BA
    Can J Anaesth; 1990 Jul; 37(5):556-9. PubMed ID: 2372858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.